Potential path could mean many things. It could be a approval might come if you were to agree to a deal of all doses currently in hand are to be used in the USA. That’s one example. It could be as simple as a EUA approval with a phase 4 confirmation follow up that’s another potential path
Either of those would have been announced in the PR. Cytodyn would not shy away from trumpeting those to the high heavens. Announcement of DSMC results in a CC only makes sense in terms of softening the blow. Yes, trial continuation is positive but not compared to an interim EUA submission.